FACTORS INFLUENCING ON SCD PATIENT'S FAMILY AND CAREGIVERS IN AL-QUNFUDAH GOVERNORATE, SAUDI ARABIA
Main Article Content
Keywords
Sickle cell disease, haematological disorder, caregivers, Al- Qunfudah, Saudi Arabia
Abstract
Background: Sickle cell disease (SCD) is a common hereditary haematological disorder affecting millions worldwide. The current study aimed to improve the quality of life in SCA patients by Periodic psychological assessment and early detection of psychological effects, optimizing the patient's and family's adaptation to the illness. Methodology: This study was a survey-based cross- sectional study conducted in Al-Qunfudah governorate, Saudi Arabia. Sickle Cell Disease Burden Interview (SCDBI) vailed questionnaire was used in interviewing the participants. Results: A total of 107 participants participated in the study. The vast majority of the samples have SCA alone 50.47%, with one child with SCA 46.73%. Conclusion: Early discovery of the psychological effect of SCD is the fundamental goal to achieve to optimize the patient's and family's adaptation to the illness.
Downloads
References
1. Adegoke SA, Kuteyi EA. Psychosocial burden of sickle cell disease on the family, Nigeria. Afr J Prim Health Care Fam Med 2012; 4(1):1-6. 2. Al Zahrani OS, Mukhtar O, Al Subaie M, Al Howiti WE. Systematic psychiatric assessment of patients with sickle cell disease. Saudi Med J 2019; 40(1):59–65. 3. Alao AO, Cooley E. Depression and sickle cell disease. Harv Rev Psychiatry 2001; 9(4):169‐177. 4. Albagshi M, Altaweel H, AlAlwan M, AlHashem H, Albagshi M, AlHabeeb F, AlAmeer H, A Bushehab A. Sickle cell disease awareness among school children in Saudi Arabia. Int J Med Dev Ctries 2019; 28–31. 5. AlHamdan NAR, AlMazrou YY, AlSwaidi FM, Choudhry AJ. Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genet Med 2007; 9(6):372–7. 6. Alhomoud M, Gosadi I, Wahbi H. Depression among sickle cell anemia patients in the Eastern Province of Saudi Arabia. Saudi J Med Med Sci. 2018; 6(1):8-12. 7. Al-Saqladi AWM. The impact of sickle cell disease severity on school performance in affected Yemeni children. J Appl Hematol 2016; 7(4):124. 8. Bairwa M, Rajput M, Sachdeva S. Modified kuppuswamy's socioeconomic scale: social researcher should include updated income criteria, 2012. Indian J Comm Med 2013; 38(3):185-6. 9. Bakri M, Ismail E, Elsedfy G, Amr M, Ibrahim A. Behavioral impact of sickle cell disease in young children with repeated hospitalization. Saudi J Anaesth 2014; 8(4):504–9. 10. Brown BJ, Okereke JO, Lagunju IA, Orimadegun AE, Ohaeri JU, Akinyinka OO. Burden of health-care of carers of children with sickle cell disease in Nigeria. Health Soc care community. Wiley Online Library. 2010; 18(3):289–95. 11. Buchanan G, Vichinsky E, Krishnamurti L, Shenoy S. Severe Sickle Cell Disease—Pathophysiology and Therapy. Biol Blood Marrow Transplant 2010; 16(1):S64-S7. 12. Canadian Haemoglobinopathy Association. An introduction to sickle cell disease. In: Consensus Statement on the Care of Patients with Sickle Cell Disease in Canada Version 2 0 Ottawa; 2015 pp 7 13. Collins M, Kaslow N, Doepke K, Eckman J, Johnson M. Psychosocial interventions for children and adolescents with sickle cell disease (scd). J Black Psychol 1998; 24(4):432–54. 14. Edwards CL1, Scales MT, Loughlin C, Bennett GG, Harris- Peterson S, De Castro LM, Whitworth E, Abrams M, Feliu M, Johnson S, Wood M, Harrison O KA. A brief review of the pathophysiology, associated pain, and psychosocial issues in sickle cell disease. Int J Behav Med 2005; 12(3):171– 9. 15. el-Hazmi MA ,Warsy AS. Appraisal of sickle-cell and thalassaemia genes in Saudi Arabia. East Mediterr Heal J 1999; 5(6):1147-53. 16. Graves JK, Hodge C, Jacob E. Depression, Anxiety, and Quality of Life in Children and Adolescents with Sickle Cell Disease. Pediatr Nurs 2016; 42(3):113-9, 144. 17. Hasan SP, Hashmi S, Alhassen M, Lawson W, Castro O. Depression in sickle cell disease. J Natl Med Assoc 2003; 95(7):533–537. 18. Hijmans CT, Grootenhuis MA, Oosterlaan J, Last BF, Heijboer H, Peters M, Fijnvandraat K . Behavioral and emotional problems in children with sickle cell disease and healthy siblings: Multiple informants, multiple measures. Pediatr Blood Canc 2009; 53(7):1277–83. 19. Jastaniah W. Epidemiology of sickle cell disease in Saudi Arabia. Ann Saudi Med 2011; 31(3):289–293 20. Karimeldin MA Salih. The impact of sickle cell anemia on the quality of life of sicklers at school age. J Fam Med Prim Care 2019; 8(2):468–471. 21. Klaufus L, Verlinden E, van der Wal M, Kösters M, Cuijpers P, Chinapaw M. Psychometric evaluation of two short versions of the Revised Child Anxiety and Depression Scale. BMC Psychiatry 2020; 20(1):47. 22. Lane PA, Buchanan GR, Desposito F, Pegelow CH, Vichinsky EP, Woods Gerald M. Health supervision for children with sickle cell disease. Pediatrics 2003; 111(3):710– 1. 23. Leavell S, Ford CV. Psychopathology in patients with sickle cell disease. Psychosomatics 1983; 24(1):23–5 24. Levenson JL, McClish DK, Dahman BA, Bovbjerg VE, de A Citero V, Penberthy LT, Aisiku IP, Roberts JD, Roseff SD, Smith WR. Depression and anxiety in adults with sickle cell disease: the PiSCES project. Psychosom Med 2008; 70(2):192- 6. 25. Madani BM, Al Raddadi R, Al Jaouni S, Omer M, Al Awa MI. Quality of life among caregivers of sickle cell disease patients: a cross sectional study. Health Qual Life Outcomes 2018; 16(1):176. 26. Menezes AS, Len CA, Hilário MO, Terreri MT, Braga JA. Quality of life in patients with sickle cell disease. Rev Paul Pediatr 2013; 31(1):24-9. 27. Milaat WA, Ibrahim NK, Albar HM. Reproductive health profile and circumcision of females in the Hali semi-urban region, Saudi Arabia: A community-based cross sectional survey. Ann Saudi Med 2018; 38(2):81–9. 28. Morgan SA, Jackson J. Psychological and social concomitants of sickle cell anemia in adolescents. J Pediatr Psychol 1986; 11(3):429-40 29. National Heart, Lung, and Blood Institute. Management and Therapy of Sickle Cell Disease. 4th ed. Bethesda, MD: National Institutes of Health; 2002. In press 30. Ohaeri JU, Shokunbi WA. Psychosocial burden of sickle cell disease on caregivers in a Nigerian setting. J Natl Med Assoc 2002; 94(12):1058-70. 31. Pass KA, Lane PA, Fernhoff PM, Hinton CF, Panny SR, Parks JS, Pelias MZ, Rhead WJ, Ross SI, Wethers DL, EL 2nd. US newborn screening system guidelines II: follow-up of children, diagnosis, management, and evaluation. Statement of the Council of Regional Networks for Genetic Services (CORN). J Pediatr 2000; 137(4):S1-46. 32. Pinto VM, Balocco M, Quintino S, Forni GL. Sickle cell disease: a review for the internist. Intern Emerg Med 2019; 14(7):1051-1064. 33. Rattler TL, Walder AM, Feng H, Raphael JL. Care coordination for children with sickle cell disease: A Longitudinal Study of Parent Perspectives and Acute Care Utilization. Am J Prev Med Elsevier 2016; 51(1):S55–61 34. Sehlo MG, Kamfar HZ. Depression and quality of life in children with sickle cell disease: The effect of social support. BMC Psychiatry 2015; 15(1):1–8. 35. Sogutlu A, Levenson JL, McClish DK, Rosef SD, Smith WR. Somatic symptom burden in adults with sickle cell disease predicts pain, depression, anxiety, health care utilization, and quality of life: the PiSCES project. Psychosomatics 2011; 52(3):271–9. 36. Tunde-Ayinmode MF. Psychosocial impact of sickle cell disease on mothers of affected children seen at University of Ilorin Teaching Hospital, Ilorin, Nigeria. East Afr Med J 2007; 84(9):410–419. 37. Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care 2001; 39(8):800-12. 38. Welkom JS. The impact of Sickle Cell Disease on the family: an examination of the illness intrusiveness framework 2012. 39. Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, Jordan L. Lanzkron SM, Lottenberg R, Savage WJ, Tanabe PJ, Ware RE, Murad MH, Goldsmith JC, Ortiz E, Fulwood R, Horton A, John-Sowah J. Management of Sickle Cell Disease: Summary of the 2014 Evidence-Based Report by Expert Panel Members. AMA. 2014; 312(10):1033–48.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.